(Circulation. 1999;100:1132-1133.)
© 1999 American Heart Association, Inc.
Joint Editorial Statement |
Diabetes Mellitus: A Major Risk Factor for Cardiovascular Disease
A Joint Editorial Statement by the American Diabetes Association; the National Heart, Lung, and Blood Institute; the Juvenile Diabetes Foundation International; the National Institute of Diabetes and Digestive and Kidney Diseases; and the American Heart Association
Key Words: AHA Scientific Statements • diabetes mellitus • risk factors • cardiovascular diseases
 |
Introduction |
|---|
Abundant evidence shows that patients with type 1 diabetes or type 2 diabetes are at high risk for several cardiovascular disorders: coronary heart disease, stroke, peripheral arterial disease, cardiomyopathy, and congestive heart failure. Cardiovascular complications are now the leading causes of diabetes-related morbidity and mortality. The public health impact of cardiovascular disease (CVD) in patients with diabetes is already enormous and is increasing. Several explanations are behind this increase. First, the incidence of diabetes rises with advancing age, and the number of older people in the United States is growing rapidly. Second, insulin treatment for persons with type 1 diabetes has prolonged their lives significantly, and with each year of additional life comes an increased risk for CVD complications. Third, type 2 diabetes occurs at an earlier age in obese and overweight persons, and the prevalence of obesity is rising in the United States. The risk for diabetes in overweight persons is heightened by physical inactivity; unfortunately, the majority of Americans engage in little regular or sustained physical activity. Fourth, the populations that are particularly susceptible to diabetes—African Americans, Hispanics, Native Americans, Pacific Islanders, and Asians—are growing in this country. Fifth, improved medical care, particularly when extended to susceptible populations, will bring an increasing number of patients with type 2 diabetes into the medical care system. All of these factors will lead to an absolute increase in the number of patients who will require medical intervention to prevent the complications of diabetes.
Diabetes has long been recognized to
This article has been cited by other articles:
 |
|
 |
|
  D. Aguilar, B. Bozkurt, K. Ramasubbu, and A. Deswal Relationship of hemoglobin A1C and mortality in heart failure patients with diabetes. J. Am. Coll. Cardiol., July 28, 2009; 54(5): 422 - 428. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. A. Lesniewski, A. J. Donato, B. J. Behnke, C. R. Woodman, M. H. Laughlin, C. A. Ray, and M. D. Delp Decreased NO signaling leads to enhanced vasoconstrictor responsiveness in skeletal muscle arterioles of the ZDF rat prior to overt diabetes and hypertension Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1840 - H1850. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. B. Buse, H. N. Ginsberg, G. L. Bakris, N. G. Clark, F. Costa, R. Eckel, V. Fonseca, H. C. Gerstein, S. Grundy, R. W. Nesto, et al. Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus: A Scientific Statement From the American Heart Association and the American Diabetes Association Circulation, January 2, 2007; 115(1): 114 - 126. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. B. Buse, H. N. Ginsberg, G. L. Bakris, N. G. Clark, F. Costa, R. Eckel, V. Fonseca, H. C. Gerstein, S. Grundy, R. W. Nesto, et al. Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus: A scientific statement from the American Heart Association and the American Diabetes Association Diabetes Care, January 1, 2007; 30(1): 162 - 172. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ahmed, C. P. Cannon, S. A. Murphy, and E. Braunwald Acute coronary syndromes and diabetes: is intensive lipid lowering beneficial? Results of the PROVE IT-TIMI 22 trial Eur. Heart J., October 1, 2006; 27(19): 2323 - 2329. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Costa, M. Borges, C. David, and A. Vaz Carneiro Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: meta-analysis of randomised controlled trials BMJ, May 13, 2006; 332(7550): 1115 - 1124. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Grundy Metabolic Syndrome: Connecting and Reconciling Cardiovascular and Diabetes Worlds J. Am. Coll. Cardiol., March 21, 2006; 47(6): 1093 - 1100. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Abdelghaffar, M. El Amir, A. El Hadidi, and F. El Mougi Carotid Intima-Media Thickness: An Index for Subclinical Atherosclerosis in Type 1 Diabetes J Trop Pediatr, February 1, 2006; 52(1): 39 - 45. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Raggi, A. Bellasi, and C. Ratti Ischemia Imaging and Plaque Imaging in Diabetes: Complementary tools to improve cardiovascular risk management Diabetes Care, November 1, 2005; 28(11): 2787 - 2794. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. W. Strum, R. Hopkins, D. S. West, and B. N. Harris Effects of a medication assistance program on health outcomes in patients with type 2 diabetes mellitus Am. J. Health Syst. Pharm., May 15, 2005; 62(10): 1048 - 1052. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Venturini, E. Angeli, P. Maffi, P. Fiorina, F. Bertuzzi, M. Salvioni, F. De Cobelli, C. Socci, L. Aldrighetti, C. Losio, et al. Technique, Complications, and Therapeutic Efficacy of Percutaneous Transplantation of Human Pancreatic Islet Cells in Type 1 Diabetes: The Role of US Radiology, February 1, 2005; 234(2): 617 - 624. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Aguilar, S. D. Solomon, L. Kober, J.-L. Rouleau, H. Skali, J. J.V. McMurray, G. S. Francis, M. Henis, C. M. O'Connor, R. Diaz, et al. Newly Diagnosed and Previously Known Diabetes Mellitus and 1-Year Outcomes of Acute Myocardial Infarction: The Valsartan in Acute Myocardial Infarction (VALIANT) Trial Circulation, September 21, 2004; 110(12): 1572 - 1578. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Fiorina, F. Folli, A. D'Angelo, G. Finzi, F. Pellegatta, V. Guzzi, C. Fedeli, P. D. Valle, L. Usellini, C. Placidi, et al. Normalization of Multiple Hemostatic Abnormalities in Uremic Type 1 Diabetic Patients After Kidney-Pancreas Transplantation Diabetes, September 1, 2004; 53(9): 2291 - 2300. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Charbonnel, J. Dormandy, E. Erdmann, M. Massi-Benedetti, and A. Skene The Prospective Pioglitazone Clinical Trial in Macrovascular Events (PROactive): Can pioglitazone reduce cardiovascular events in diabetes? Study design and baseline characteristics of 5,238 patients Diabetes Care, July 1, 2004; 27(7): 1647 - 1653. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. W. Grant, P. A. Pirraglia, J. B. Meigs, and D. E. Singer Trends in Complexity of Diabetes Care in the United States From 1991 to 2000 Arch Intern Med, May 24, 2004; 164(10): 1134 - 1139. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Fetterolf and R. West The Business Case for Quality: Combining Medical Literature Research with Health Plan Data to Establish Value for Nonclinical Managers American Journal of Medical Quality, March 1, 2004; 19(2): 48 - 55. [Abstract] [PDF]
|
|
|
|
 |
|
 E. R. Chasens, T. E. Weaver, and M. G. Umlauf Insulin Resistance and Obstructive Sleep Apnea: Is Increased Sympathetic Stimulation the Link? Biol Res Nurs, October 1, 2003; 5(2): 87 - 96. [Abstract] [PDF]
|
|
|
|
|
|
Committee Members, F. J. Klocke, M. G. Baird, B. H. Lorell, T. M. Bateman, J. V. Messer, D. S. Berman, P. T. O'Gara, B. A. Carabello, R. O. Russell Jr, et al. ACC/AHA/ASNC Guidelines for the Clinical Use of Cardiac Radionuclide Imaging--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging) J. Am. Coll. Cardiol., October 1, 2003; 42(7): 1318 - 1333. [Full Text] [PDF]
|
|
|
|
|
|
A. Keech, D. Colquhoun, J. Best, A. Kirby, R. J. Simes, D. Hunt, W. Hague, E. Beller, M. Arulchelvam, J. Baker, et al. Secondary Prevention of Cardiovascular Events With Long-Term Pravastatin in Patients With Diabetes or Impaired Fasting Glucose: Results from the LIPID trial Diabetes Care, October 1, 2003; 26(10): 2713 - 2721. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. J. Klocke, M. G. Baird, B. H. Lorell, T. M. Bateman, J. V. Messer, D. S. Berman, P. T. O'Gara, B. A. Carabello, R. O. Russell Jr, M. D. Cerqueira, et al. ACC/AHA/ASNC Guidelines for the Clinical Use of Cardiac Radionuclide Imaging--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging) Circulation, September 16, 2003; 108(11): 1404 - 1418. [Full Text] [PDF]
|
|
|
|
|
|
R. W. Grant, H. E. Hamrick, C. M. Sullivan, A. K. Dubey, H. C. Chueh, E. Cagliero, and J. B. Meigs Impact of Population Management With Direct Physician Feedback on Care of Patients With Type 2 Diabetes Diabetes Care, August 1, 2003; 26(8): 2275 - 2280. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Fiorina, F. Folli, F. Bertuzzi, P. Maffi, G. Finzi, M. Venturini, C. Socci, A. Davalli, E. Orsenigo, L. Monti, et al. Long-Term Beneficial Effect of Islet Transplantation on Diabetic Macro-/Microangiopathy in Type 1 Diabetic Kidney-Transplanted Patients Diabetes Care, April 1, 2003; 26(4): 1129 - 1136. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. E. Eberly, J. D. Cohen, R. Prineas, and L. Yang Impact of Incident Diabetes and Incident Nonfatal Cardiovascular Disease on 18-Year Mortality: The Multiple Risk Factor Intervention Trial experience Diabetes Care, March 1, 2003; 26(3): 848 - 854. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Ryerson, E. F. Tierney, T. J. Thompson, M. M. Engelgau, J. Wang, E. W. Gregg, and L. S. Geiss Excess Physical Limitations Among Adults With Diabetes in the U.S. Population, 1997-1999 Diabetes Care, January 1, 2003; 26(1): 206 - 210. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Iozzo, P. Chareonthaitawee, D. Dutka, D. J. Betteridge, E. Ferrannini, and P. G. Camici Independent Association of Type 2 Diabetes and Coronary Artery Disease With Myocardial Insulin Resistance Diabetes, October 1, 2002; 51(10): 3020 - 3024. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. R. Chasens, M. Q. Umlauf, D. J. Pillion, and J. A. Wells Nocturnal Polyuria in Type 2 Diabetes: A Symptom of Obstructive Sleep Apnea The Diabetes Educator, May 1, 2002; 28(3): 424 - 434. [Abstract] [PDF]
|
|
|
|
|
|
L. E. Egede and D. Zheng Modifiable Cardiovascular Risk Factors in Adults With Diabetes: Prevalence and Missed Opportunities for Physician Counseling Arch Intern Med, February 25, 2002; 162(4): 427 - 433. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. J. Th. Wackers and B. L. Zaret Detection of Myocardial Ischemia in Patients With Diabetes Mellitus Circulation, January 1, 2002; 105(1): 5 - 7. [Full Text] [PDF]
|
|
|
|
|
|
S. C. Smith Jr, S. N. Blair, R. O. Bonow, L. M. Brass, M. D. Cerqueira, K. Dracup, V. Fuster, A. Gotto, S. M. Grundy, N. H. Miller, et al. AHA/ACC Guidelines for Preventing Heart Attack and Death in Patients With Atherosclerotic Cardiovascular Disease: 2001 Update: A Statement for Healthcare Professionals From the American Heart Association and the American College of Cardiology Circulation, September 25, 2001; 104(13): 1577 - 1579. [Full Text] [PDF]
|
|
|
|
|
|
P. Fiorina, E. La Rocca, M. Venturini, F. Minicucci, I. Fermo, R. Paroni, A. D’Angelo, M. Sblendido, V. Di Carlo, M. Cristallo, et al. Effects of Kidney-Pancreas Transplantation on Atherosclerotic Risk Factors and Endothelial Function in Patients With Uremia and Type 1 Diabetes Diabetes, March 1, 2001; 50(3): 496 - 501. [Abstract] [Full Text]
|
|
|
|
 |
|
 G. S FRANCIS Diabetic cardiomyopathy: fact or fiction? Heart, March 1, 2001; 85(3): 247 - 248. [Full Text]
|
|
|
|
|
|
S. Schurgin, S. Rich, and T. Mazzone Increased Prevalence of Significant Coronary Artery Calcification in Patients With Diabetes Diabetes Care, February 1, 2001; 24(2): 335 - 338. [Abstract] [Full Text]
|
|
|
|
|
|
J. A. D'Elia, L. A. Weinrauch, R. E. Gleason, I. Lipinska, J. Keough, S. Pendse, B. Roshan, A. T. Lee, and G. H. Tofler Fibrinogen and Factor VII Levels Improve With Glycemic Control in Patients With Type 1 Diabetes Mellitus Who Have Microvascular Complications Arch Intern Med, January 8, 2001; 161(1): 98 - 101. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Grover, L. Coupal, H. Zowall, C. M. Alexander, T. W. Weiss, and D. R.J. Gomes How Cost-Effective Is the Treatment of Dyslipidemia in Patients With Diabetes but Without Cardiovascular Disease? Diabetes Care, January 1, 2001; 24(1): 45 - 50. [Abstract] [Full Text]
|
|
|
|
|
|
S. M. Grundy, T. Bazzarre, J. Cleeman, R. B. D’Agostino Sr, M. Hill, N. Houston-Miller, W. B. Kannel, R. Krauss, H. M. Krumholz, R. M. Lauer, et al. Prevention Conference V : Beyond Secondary Prevention : Identifying the High-Risk Patient for Primary Prevention : Medical Office Assessment : Writing Group I Circulation, January 4, 2000; 101 (1): e3 - e11. [Full Text] [PDF]
|
|